Danaher Corporation (NYSE:DHR) will be issuing its quarterly earnings data on Thursday, July 20th. Analysts expect the company to announce earnings of $0.97 per share for the quarter. Danaher Corporation has set its Q2 guidance at $0.95-0.98 EPS and its FY17 guidance at $3.85-3.95 EPS.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, April 20th. The conglomerate reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.84 by $0.01. The company had revenue of $4.21 billion during the quarter, compared to analysts’ expectations of $4.17 billion. Danaher Corporation had a return on equity of 11.82% and a net margin of 12.30%. Danaher Corporation’s revenue for the quarter was up 7.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.08 earnings per share. On average, analysts expect Danaher Corporation to post $3.93 EPS for the current fiscal year and $4.28 EPS for the next fiscal year.

Danaher Corporation (DHR) opened at 85.47 on Tuesday. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.01. The firm has a market capitalization of $59.33 billion, a PE ratio of 26.05 and a beta of 1.05. The stock’s 50 day moving average price is $84.47 and its 200 day moving average price is $83.63.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 28th. Stockholders of record on Friday, June 30th will be given a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 0.66%. The ex-dividend date of this dividend is Wednesday, June 28th. Danaher Corporation’s dividend payout ratio (DPR) is presently 17.02%.

In other news, EVP William K. Daniel sold 17,444 shares of the business’s stock in a transaction that occurred on Tuesday, April 25th. The stock was sold at an average price of $83.07, for a total value of $1,449,073.08. Following the transaction, the executive vice president now owns 132,995 shares in the company, valued at approximately $11,047,894.65. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Thomas Patrick Joyce, Jr. sold 54,006 shares of the business’s stock in a transaction that occurred on Friday, April 21st. The stock was sold at an average price of $82.52, for a total value of $4,456,575.12. Following the completion of the transaction, the insider now owns 142,157 shares in the company, valued at approximately $11,730,795.64. The disclosure for this sale can be found here. Insiders sold a total of 82,265 shares of company stock worth $6,815,839 in the last 90 days. Company insiders own 12.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was first published by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/07/17/danaher-corporation-dhr-scheduled-to-post-quarterly-earnings-on-thursday.html.

Several analysts have recently commented on DHR shares. Janney Montgomery Scott downgraded Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. Cowen and Company restated an “outperform” rating and issued a $90.00 target price on shares of Danaher Corporation in a research note on Sunday, April 23rd. William Blair restated an “outperform” rating on shares of Danaher Corporation in a research note on Sunday, April 23rd. Vetr upgraded Danaher Corporation from a “buy” rating to a “strong-buy” rating and set a $94.18 target price for the company in a research note on Thursday, April 20th. Finally, Credit Suisse Group restated a “buy” rating and issued a $93.00 target price on shares of Danaher Corporation in a research note on Wednesday, May 24th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Danaher Corporation currently has a consensus rating of “Buy” and an average target price of $92.11.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Earnings History for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.